ABC² 's High Risk, High Reward Approach To Brain Cancer Research Featured in Nature

May 4, 2016

For the past decade, venture philanthropists have been working to propel promising therapies and vaccines into the clinic, with some success.  This month, Nature, one of the world's leading scientific journals, featured the bold and risk-taking approaches to medical research being championed by leading venture philanthropies, including ABC2, the Bill and Melinda Gates Foundation and the Chan Zuckerberg Initiative.

Click HERE to read full Nature article.